X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4078) 4078
Publication (380) 380
Newsletter (64) 64
Book Review (55) 55
Magazine Article (8) 8
Book Chapter (7) 7
Dissertation (6) 6
Trade Publication Article (4) 4
Book / eBook (3) 3
Conference Proceeding (2) 2
Data Set (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
citalopram (2217) 2217
male (2170) 2170
pharmacology & pharmacy (2021) 2021
humans (1978) 1978
index medicus (1501) 1501
animals (1416) 1416
psychiatry (1414) 1414
female (1369) 1369
citalopram - pharmacology (1361) 1361
neurosciences (1254) 1254
adult (1086) 1086
antidepressants (1015) 1015
serotonin uptake inhibitors - pharmacology (971) 971
rats (931) 931
citalopram - therapeutic use (828) 828
depression (781) 781
serotonin (770) 770
middle aged (758) 758
serotonin uptake inhibitors - therapeutic use (553) 553
fluoxetine (550) 550
clinical neurology (544) 544
escitalopram (514) 514
dose-response relationship, drug (452) 452
major depression (446) 446
treatment outcome (446) 446
serotonin - metabolism (442) 442
aged (420) 420
depressive disorder, major - drug therapy (417) 417
antidepressive agents - pharmacology (405) 405
citalopram - adverse effects (401) 401
citalopram - administration & dosage (396) 396
double-blind method (386) 386
major depressive disorder (375) 375
rats, sprague-dawley (370) 370
mice (365) 365
brain (363) 363
serotonin uptake inhibitors (351) 351
paroxetine (346) 346
antidepressant (343) 343
adolescent (340) 340
double-blind (334) 334
antidepressive agents - therapeutic use (330) 330
serotonin reuptake inhibitors (315) 315
depression, mental (313) 313
young adult (294) 294
time factors (292) 292
analysis (280) 280
rats, wistar (276) 276
serotonin uptake inhibitors - adverse effects (273) 273
drug therapy (271) 271
serotonin uptake inhibitors - administration & dosage (268) 268
depressive disorder - drug therapy (261) 261
anxiety (259) 259
drugs (259) 259
pharmacology/toxicology (253) 253
depression - drug therapy (251) 251
research (251) 251
brain - drug effects (247) 247
drug interactions (247) 247
antidepressive agents, second-generation - therapeutic use (246) 246
brain - metabolism (241) 241
ssri (240) 240
sertraline (237) 237
pharmacology (230) 230
psychiatric status rating scales (226) 226
fluoxetine - pharmacology (223) 223
efficacy (219) 219
serotonin antagonists - pharmacology (202) 202
citalopram - pharmacokinetics (196) 196
microdialysis (196) 196
pharmacokinetics (191) 191
disease models, animal (187) 187
rat (185) 185
article (184) 184
behavior, animal - drug effects (183) 183
antidepressive agents, second-generation - pharmacology (182) 182
mental disorders (180) 180
medicine & public health (179) 179
5-ht (178) 178
dosage and administration (178) 178
rat-brain (178) 178
risk factors (177) 177
mental depression (174) 174
fluvoxamine (173) 173
biochemistry & molecular biology (171) 171
venlafaxine (170) 170
hippocampus - drug effects (167) 167
analysis of variance (166) 166
health aspects (165) 165
in-vivo (163) 163
serotonin transporter (158) 158
dopamine (154) 154
serotonin uptake inhibitors - pharmacokinetics (154) 154
imipramine (151) 151
biomedicine (150) 150
motor activity - drug effects (149) 149
complications and side effects (145) 145
placebo (145) 145
hippocampus (143) 143
neurology (142) 142
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4087) 4087
German (24) 24
Japanese (9) 9
Chinese (8) 8
French (8) 8
Russian (7) 7
Hungarian (4) 4
Spanish (3) 3
Turkish (3) 3
Italian (2) 2
Polish (2) 2
Swedish (2) 2
Danish (1) 1
Dutch (1) 1
Norwegian (1) 1
Portuguese (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neuroendocrinology Letters, ISSN 0172-780X, 2010, Volume 31, Issue 5, pp. 645 - 656
Journal Article
Journal Article
Journal Article
Biochemical Journal, ISSN 0264-6021, 11/2012, Volume 448, Issue 1, pp. 93 - 102
The discovery of epigenetic processes as possible pivotal regulatory mechanisms in psychiatric diseases raised the question of how psychoactive drugs may... 
Antidepressant | Epigenetics | Histone methyltransferase | DNA methyltransferase 1 (DNMT1) | Astrocyte | Mood stabilizer | METHYLATION | INDUCE | BIOCHEMISTRY & MOLECULAR BIOLOGY | antidepressant | FLUVOXAMINE | mood stabilizer | FLUOXETINE | epigenetics | P-GLYCOPROTEIN | histone methyltransferase | GDNF | PHARMACOKINETICS | DEMETHYLATION | IN-VIVO | astrocyte | BRAIN | Citalopram - pharmacology | Maleimides - pharmacology | Astrocytes - enzymology | DNA (Cytosine-5-)-Methyltransferases - antagonists & inhibitors | Cerebral Cortex - cytology | DNA (Cytosine-5-)-Methyltransferases - metabolism | Histone-Lysine N-Methyltransferase - antagonists & inhibitors | Neurons - physiology | Indoles - pharmacology | Antidepressive Agents - pharmacology | Cyclohexanols - pharmacology | Neurons - drug effects | Astrocytes - drug effects | Carbamazepine - pharmacology | Nerve Tissue Proteins - antagonists & inhibitors | Cells, Cultured - drug effects | Histone-Lysine N-Methyltransferase - pharmacology | DNA (Cytosine-5-)-Methyltransferase 1 | Enzyme Inhibitors - pharmacology | Glycolipids - pharmacology | Neural Stem Cells - drug effects | Cells, Cultured - physiology | Neural Stem Cells - physiology | Rats | Recombinant Proteins - pharmacology | Neural Stem Cells - enzymology | Rats, Sprague-Dawley | Cells, Cultured - enzymology | Protein Interaction Mapping | Nerve Tissue Proteins - metabolism | Venlafaxine Hydrochloride | Astrocytes - physiology | Animals | Cerebral Cortex - embryology | Histone-Lysine N-Methyltransferase - metabolism | Neurons - enzymology | Mice | Imipramine - pharmacology | Paroxetine - pharmacology | DNA Methylation - drug effects
Journal Article
Psychopharmacology, ISSN 0033-3158, 2012, Volume 219, Issue 2, pp. 313 - 326
High levels of impulsivity are a core symptom of psychiatric disorders such as ADHD, mania, personality disorders and drug addiction. The effectiveness of... 
Neurosciences | Impulsivity | Biomedicine | Dopamine | Serotonin | Delayed reward | Pharmacology/Toxicology | Psychiatry | Noradrenaline | Five-choice serial reaction time task | PSYCHIATRY | GLOBAL 5-HT DEPLETION | DEFICIT-HYPERACTIVITY DISORDER | TERM ATOMOXETINE TREATMENT | NEUROSCIENCES | REACTION-TIME-TASK | PREFRONTAL CORTEX | ATTENTION-DEFICIT/HYPERACTIVITY DISORDER | RESPONSE-INHIBITION | NUCLEUS-ACCUMBENS CORE | NOREPINEPHRINE TRANSPORTER | PHARMACOLOGY & PHARMACY | D-AMPHETAMINE | Citalopram - pharmacology | Dopamine Uptake Inhibitors - therapeutic use | Male | Dose-Response Relationship, Drug | Time Factors | Reaction Time - drug effects | Atomoxetine Hydrochloride | Serial Learning - drug effects | Animals, Outbred Strains | Choice Behavior - drug effects | Adrenergic Uptake Inhibitors - therapeutic use | Dopamine Uptake Inhibitors - pharmacology | Amphetamine - therapeutic use | Amphetamine - pharmacology | Serotonin Uptake Inhibitors - therapeutic use | Rats | Piperazines - therapeutic use | Piperazines - pharmacology | Animals | Propylamines - therapeutic use | Adrenergic Uptake Inhibitors - pharmacology | Citalopram - therapeutic use | Impulsive Behavior - drug therapy | Propylamines - pharmacology | Serotonin Uptake Inhibitors - pharmacology | Antidepressants | Mental illness | Neurotransmitters | Inhibitor drugs | Response time | Animal behavior | Rodents | Psychopharmacology | Drug abuse | Drug addiction | Mental disorders | Attention deficit hyperactivity disorder | impulsive behavior | Drug delivery | Personality | Reaction time task | Intertrial interval | Amphetamine | Affective disorders | Reinforcement | Norepinephrine | citalopram | Neurotransmission | monoamines | Original Investigation
Journal Article
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 09/2017, Volume 12, Issue 9, pp. 1409 - 1417
Journal Article
Behavioural Pharmacology, ISSN 0955-8810, 09/2014, Volume 25, Issue 5 and 6, pp. 518 - 531
Journal Article
Neuropharmacology, ISSN 0028-3908, 04/2014, Volume 79, pp. 222 - 233
Journal Article